Gut sulfide metabolism modulates behavior and brain bioenergetics
Abstract
The host–microbiome interface is rich in metabolite exchanges and exquisitely sensitive to diet. Hydrogen sulfide (H 2 S) is present at high concentrations at this interface and is a product of both microbial and host metabolism. The mitochondrial enzyme, sulfide quinone oxidoreductase (SQOR), couples H 2 S detoxification to oxidative phosphorylation; its inherited deficiency presents as Leigh disease. Since an estimated two-thirds of systemic H 2 S metabolism originates in the gut, it raises questions as to whether impaired sulfide clearance in this compartment contributes to disease and whether it can be modulated by dietary sulfur content. In this study, we report that SQOR deficiency confined to murine intestinal epithelial cells perturbs colon bioenergetics that is reversed by antibiotics, revealing a significant local contribution of microbial H 2 S to host physiology. We also find that a 2.5-fold higher methionine intake, mimicking the difference between animal and plant proteins, synergizes with intestinal SQOR deficiency to adversely impact colon architecture and alter microbiome composition. In serum, increased thiosulfate, a biomarker of H 2 S oxidation, reveals that intestinal SQOR deficiency combined with higher dietary methionine affects sulfide metabolism globally and perturbs energy metabolism as indicated by higher ketone bodies. The mice exhibit lower exploratory locomotor activity while brain MRI reveals an atypical reduction in ventricular volume, which is associated with lower aquaporin 1 that is important for cerebrospinal fluid secretion. Our study reveals the dynamic interaction between dietary sulfur intake and sulfide metabolism at the host–microbe interface, impacting gut health, and the potential for lower dietary methionine intake to modulate pathology.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (14)
Roshan Kumar
Delawrence J. Sykes
Department of Biology, Berry College
Victor I. Band
Megan L. Schaller
Department of Molecular and Integrative Physiology, University of Michigan
Romel Patel
Department of Biological Chemistry, University of Michigan
Victor Vitvitsky
Department of Biological Chemistry, University of Michigan
Peter Sajjakulnukit
Rashi Singhal
Harrison K. A. Wong
Department of Molecular and Integrative Physiology, University of Michigan
Suchitra K. Hourigan
Clinical Microbiome Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Fumito Ichinose
Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School
Costas A. Lyssiotis
Yatrik M. Shah
Ruma Banerjee